DXB 3.45% 45.0¢ dimerix limited

Hi Eddie,Totally understand the connection between COVID-19 &...

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274
    Hi Eddie,

    Totally understand the connection between COVID-19 & DMX-700, a few of us were wondering about that before the ANN came out & the pulmonary connection there, but that is still in pre-clinical, so it kind of didn’t make sense in a PH4 trial. DMX-200 does on the new RAAS arm, and reflecting on comments from Dimerix, that we are in a unique position here, I’m just wondering when this protocol is published on REMAP-CAP website, will DMX-200 + ARB possibly be the only drug at this point in time?

    It’s still an IND so that in itself to convince the International REMAP-CAP medical advisory board to include DMX-200 on the trial is pretty special, there would have to be very compelling evidence. I did bring my laptop home from work this weekend so will do some searches on CIAP & share here.


 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
45.0¢
Change
0.015(3.45%)
Mkt cap ! $247.7M
Open High Low Value Volume
44.0¢ 46.5¢ 42.5¢ $1.090M 2.454M

Buyers (Bids)

No. Vol. Price($)
3 63703 45.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 35469 2
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.